Author:
Torpey Nick,Bradley J. Andrew,Fung John J.
Reference113 articles.
1. Henderson DJ, Naya I, Bundick RV, et al. Comparison of the effects of FK-506, cyclosporin A and rapamycin on IL-2 production. Immunology 1991;73:316.
2. Siekierka JJ, Hung SHY, Poe M, et al. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophillin. Nature 1989;341:755.
3. Harding MW, Galat A, Uehling DE, et al. A receptor for the immunosuppressant FK506 is cistrans peptidyl-prolyl isomerase. Nature 1989;341:758.
4. Freeman DJ. Pharmacology and pharmacokinetics of cyclosporine. Clin Biochem 1991;24:9.
5. Watkins PB. The role of cytochromes P-450 in cyclosporine metabolism. J Am Acad Dermatol 1990;23:1301.